Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status was updated to indicate the study is no longer enrolling participants. The record revision was updated to version 3.6.0, replacing the prior 3.5.5 in the history.SummaryDifference0.3%

- Check21 days agoChange DetectedA new revision label 'Revision: v3.5.5' has been added to the study history, replacing the previous 'Revision: v3.5.4' and indicating an update to the record's revision level.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added to the page history. This replaces the previous 'Revision: v3.5.3' in the history and signals an update to the record's revision metadata.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s software/version footer was updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check70 days agoChange DetectedThe study history shows a new revision label, v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.5.0 was added to the record history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.